Skip to main content

Table 7 Sensitivity, specificity, PPV, NPV, and accuracy of PET/CT and BMB

From: PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma

   Sensitivity 95% CI Specificity 95% CI PPV 95% CI NPV 95% CI Accuracy 95% CI
Whole study PETCT 95.6 (89.3-100) 98 (95.2-100) 95.6 (89.3-100) 98 (95.2-100) 97.2 (94.5-99.9)
BMB 46.7 (31.5-61.8) 100 100 80.6 (73.6-87.7) 83.4 (77.3-89.6)
HD PETCT 94.1 (81.6-100) 97.2 (93.2-100) 88.9 (72.8-100) 98.6 (95.7-100) 96.6 (92.7-100)
BMB 35.3 (10-60.6) 100 100 86.6 (79.1-94.1) 87.5 (80.5-94.5)
NHL PETCT 96.4 (89.1-100) 100 100 96.7 (89.8-100) 98.2 (94.7-100)
BMB 53.6 (33.9-73.3) 100 100 69.0 (54.5-83.6) 77.2 (66.0-88.4)
Nodular sclerosis PETCT 88.9 (63.3-100) 95 (87.9-100) 80 (49.8-100) 97.4 (92.2-100) 93.9 (86.9-100)
BMB 33.3 (0.0-71.8) 100 100 87.0 (76.8-97.1) 87.8 (78.2-97.3)
Mixed cellularity PETCT 100 100 100 100 100
BMB 42.9 (0.0-92.3) 100 100 82.6 (65.8-99.4) 84.6 (69.8-99.5)
DLBCL PETCT 100 100 100 100 100
BMB 53.3 (24.7-81.9) 100 100 63.2 (39.3-87.0) 74.1 (56.4-91.7)